Novel Sulfones with Antifungal Properties: Antifungal Activities and Interactions with Candida spp. Virulence Factors

被引:9
作者
Gizinska, Malgorzata [1 ]
Staniszewska, Monika [1 ]
Ochal, Zbigniew [2 ]
机构
[1] Natl Inst Hyg, Natl Inst Publ Hlth, Chocimska 24, PL-00791 Warsaw, Poland
[2] Warsaw Univ Technol, Fac Chem, Noakowskiego 3, PL-00664 Warsaw, Poland
关键词
Antifungal activity; anti-virulence agents; Candida spp; fungal infections; sulfone derivatives; virulence; ORGAN TRANSPLANT RECIPIENTS; PRIMARY RESISTANCE; HYDROGEN-PEROXIDE; IN-VITRO; FLUCYTOSINE RESISTANCE; ANTIMICROBIAL PEPTIDES; ASPERGILLUS INFECTIONS; ANTIBACTERIAL ACTIVITY; TARGETING VIRULENCE; FUNGAL-INFECTIONS;
D O I
10.2174/1389557518666180924121209
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Since candidiasis is so difficult to eradicate with an antifungal treatment and the existing antimycotics display many limitations, hopefully new sulfone derivatives may overcome these deficiencies. It is pertinent to study new strategies such as sulfone derivatives targeting the virulence attributes of C. albicans that differentiate them from the host. During infections, the pathogenic potential of C. albicans relies on the virulence factors as follows: hydrolytic enzymes, transcriptional factors, adhesion, and development of biofilms. In the article we explored how the above-presented C. albicans fitness and virulence attributes provided a robust response to the environmental stress exerted by sulfones upon C. albicans; C. albicans fitness and virulence attributes are fungal properties whose inactivation attenuates virulence. Our understanding of how these mechanisms and factors are inhibited by sulfones has increased over the last years. As lack of toxicity is a prerequisite for medical approaches, sulfones (non-toxic as assessed in vitro and in vivo) may prove to be useful for reducing C. albicans pathogenesis in humans. The antifungal activity of sulfones dealing with these multiple virulence factors and fitness attributes is discussed.
引用
收藏
页码:12 / 21
页数:10
相关论文
共 114 条
  • [1] Ahmad I., 2015, Int. J. Pharm. Pharm. Sci, V7, P19
  • [2] Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions
    Albrecht, A
    Felk, A
    Pichova, I
    Naglik, JR
    Schaller, M
    de Groot, P
    MacCallum, D
    Odds, FC
    Schäfer, W
    Klis, F
    Monod, M
    Hube, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (02) : 688 - 694
  • [3] Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
    Alexander, Barbara D.
    Johnson, Melissa D.
    Pfeiffer, Christopher D.
    Jimenez-Ortigosa, Cristina
    Catania, Jelena
    Booker, Rachel
    Castanheira, Mariana
    Messer, Shawn A.
    Perlin, David S.
    Pfaller, Michael A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (12) : 1724 - 1732
  • [4] Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics
    Aoki, Wataru
    Ueda, Mitsuyoshi
    [J]. PHARMACEUTICALS, 2013, 6 (08) : 1055 - 1081
  • [5] The KEX2 gene of Candida glabrata is required for cell surface integrity
    Bader, O
    Schaller, M
    Klein, S
    Kukula, J
    Haack, K
    Mühlschlegel, F
    Korting, HC
    Schäfer, W
    Hube, B
    [J]. MOLECULAR MICROBIOLOGY, 2001, 41 (06) : 1431 - 1444
  • [6] Exploiting Fungal Virulence-Regulating Transcription Factors As Novel Antifungal Drug Targets
    Bahn, Yong-Sun
    [J]. PLOS PATHOGENS, 2015, 11 (07)
  • [7] Primary resistance to flucytosine among clinical isolates of Candida spp.
    Barchiesi, F
    Arzeni, D
    Caselli, F
    Scalise, G
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (03) : 408 - 409
  • [8] Transcription factor Efg1 contributes to the tolerance of Candida albicans biofilms against antifungal agents in vitro and in vivo
    Bink, Anna
    Govaert, Gilmer
    Vandenbosch, Davy
    Kucharikova, Sona
    Coenye, Tom
    Nelis, Hans
    Van Dijck, Patrick
    Cammue, Bruno P. A.
    Thevissen, Karin
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 61 (06) : 813 - 819
  • [9] Possible role of hydrolytic enzymes (Sap, Kex2) in Candida albicans response to aromatic compounds bearing a sulfone moiety
    Bondaryk, Malgorzata
    Grabowska-Jadach, Ilona
    Ochal, Zbigniew
    Sygitowicz, Grazyna
    Staniszewska, Monika
    [J]. CHEMICAL PAPERS, 2016, 70 (10) : 1336 - 1350
  • [10] Comparison of anti-Candida albicans activities of halogenomethylsulfonyl derivatives
    Bondaryk, Malgorzata
    Ochal, Zbigniew
    Staniszewska, Monika
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (05) : 1799 - 1813